Market Overview

Sage Therapeutics (NASDAQ: SAGE)

111.88 +3.83 (3.54%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2019
Pre-Market
EPS:
REV:
-2.63



Q2 2019
Pre-Market
EPS:
REV:
-0.36
90M



Q1 2019
Pre-Market
EPS:
REV:
-1.68



Q4 2018
Pre-Market
EPS:
REV:
-1.75



Q3 2018
Pre-Market
EPS:
REV:
-1.97
-2.42
-2.63
8.68%
Q2 2018
Pre-Market
EPS:
REV:
-1.88
-1.89
-0.36
90M
-80.95%
Q1 2018
Pre-Market
EPS:
REV:
-1.52
-1.84
-1.68
-8.7%
Q4 2017
Pre-Market
EPS:
REV:
-1.50
-1.99
-1.75
-12.06%
Q3 2017
Pre-Market
EPS:
REV:
-1.15
-1.97
-1.97

Q2 2017
After-Hours
EPS:
REV:
-1.08
-1.67
-1.88
12.57%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!